Blockade of Jagged/Notch Pathway Abrogates Transforming Growth Factor β2-induced Epithelial-mesenchymal Transition in Human Retinal Pigment Epithelium Cells
Overview
Affiliations
The epithelial-mesenchymal transition (EMT) of retinal pigment epithelium (RPE) cells plays a key role in proliferative vitreoretinopathy (PVR) and proliferative diabetic retinopathy (PDR), which lead to the loss of vision. The Jagged/Notch pathway has been reported to be essential in EMT during embryonic development, fibrotic diseases and cancer metastasis. However, the function of Jagged/Notch signaling in EMT of RPE cells is unknown. Thus, we hypothesized that a crosstalk between Notch and transforming growth factor β2 (TGF-β2) signaling could induce EMT in RPE cells, which subsequently contributes to PVR and PDR. Here, we demonstrate that Jagged-1/Notch pathway is involved in the TGF-β2-mediated EMT of human RPE cells. Blockade of Notch pathway with DAPT (a specific inhibitor of Notch receptor cleavage) and knockdown of Jagged-1 expression inhibited TGF-β2-induced EMT through regulating the expression of Snail, Slug and ZEB1. Besides the canonical Smad signaling pathway, the noncanonical PI3K/Akt and MAPK pathway also contributed to TGF-β2-induced up-regulation of Jagged-1 in RPE cells. Overexpression of Jagged-1 could mimic TGF-β2 induce EMT. Our data suggest that the Jagged-1/Notch signaling pathway plays a critical role in TGF-β2-induced EMT in human RPE cells, and may contribute to the development of PVR and PDR. Inhibition of the Jagged/Notch signaling pathway, therefore, may have therapeutic value in the prevention and treatment of PVR and PDR.
Fibrotic Changes in Rhegmatogenous Retinal Detachment.
Harju N, Kauppinen A, Loukovaara S Int J Mol Sci. 2025; 26(3).
PMID: 39940795 PMC: 11817287. DOI: 10.3390/ijms26031025.
Higashijima F, Hasegawa M, Yoshimoto T, Kobayashi Y, Wakuta M, Kimura K Front Ophthalmol (Lausanne). 2024; 2:1060087.
PMID: 38983569 PMC: 11182173. DOI: 10.3389/fopht.2022.1060087.
Peterson C, Lu Y, Santiago C, Price A, McNally M, Schubert W Invest Ophthalmol Vis Sci. 2023; 64(15):39.
PMID: 38153753 PMC: 10756252. DOI: 10.1167/iovs.64.15.39.
Tian H, Chen Z, Zhu X, Ou Q, Wang Z, Wu B iScience. 2022; 25(10):105050.
PMID: 36185374 PMC: 9519511. DOI: 10.1016/j.isci.2022.105050.
Safa A J Cancer Metastasis Treat. 2021; 6.
PMID: 34841087 PMC: 8623975. DOI: 10.20517/2394-4722.2020.55.